Fuji, Japan

Hideatsu Takeuchi

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideatsu Takeuchi. Retrieved from https://idiyas.com/inventor/hideatsu-takeuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideatsu Takeuchi

Introduction

Hideatsu Takeuchi is a notable inventor based in Fuji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative compositions. His work has led to advancements that enhance the stability and effectiveness of pharmaceutical products.

Latest Patents

One of Takeuchi's key patents is a stable pharmaceutical composition. This composition comprises (E)-3,5-dihydroxy-7-[4'-4"-fluorophenyl-2'-cyclopropyl-quinolin-3'-yl]-6-heptenoic acid, or its salt or ester. The aqueous solution or dispersion of this composition has a pH ranging from 6.8 to 8. It is noteworthy for its good time-dependent stability and maintains its outward appearance even after prolonged storage.

Career Highlights

Throughout his career, Takeuchi has demonstrated a commitment to innovation in the pharmaceutical industry. His work has not only contributed to scientific knowledge but has also had practical applications in medicine.

Collaborations

Takeuchi has collaborated with several professionals in his field, including Katsumi Mashita and Toyojiro Muramatsu. These collaborations have likely enriched his research and development efforts.

Conclusion

Hideatsu Takeuchi's contributions to pharmaceutical compositions exemplify the importance of innovation in medicine. His work continues to influence the industry and improve the stability of pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…